Trial Profile
Signaling Mechanisms and Vascular Function in Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 16 Oct 2008
Price :
$35
*
At a glance
- Drugs Ruboxistaurin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacodynamics; Registrational
- 16 Oct 2008 New trial record.